rate contract for supply of injection (2026-27), streptokinase inj. 15lac, iu, heparin sodium, inj.5000 iu/ml, midazolam inj. 1mg/ml, tetanus toxoid 5 ml, vial, hydrocortisone sodium, succinate inj. 100mg, ondansetron inj i.p, 2mg/ml, hydroxy propyl methyl, cellulose usp 2% in, sterile isonic base pfs, tramadol inj. 50mg/ml, rabies immunoglobulin, 300 iu/2ml inj 2ml vial, diclofenac sodium, 75mg/ml 1ml amp iv, bolus with transcutol-p, free and surfactant, free injection, rabies antiserum 1500, i

Department Of Medical Education And Research has invited bids for the rate contract for supply of injection (2026-27), streptokinase inj. 15lac, iu, heparin sodium, inj.5000 iu/ml, midazolam inj. 1mg/ml, tetanus toxoid 5 ml, vial, hydrocortisone sodium, succinate inj. 100mg, ondansetron inj i.p, 2mg/ml, hydroxy propyl methyl, cellulose usp 2% in, sterile isonic base pfs, tramadol inj. 50mg/ml, rabies immunoglobulin, 300 iu/2ml inj 2ml vial, diclofenac sodium, 75mg/ml 1ml amp iv, bolus with transcutol-p, free and surfactant, free injection, rabies antiserum 1500, iu/5ml inj im & sc, cefotaxime sodium, 1gm inj, anti rabies monoclonal, antibody docaravimab, & miromavimab inj, 1500iu/2.5ml, frusemide 10mg/ml inj, 2ml amp, colistomithate 1 miu inj, colistimethate sodium, inj. 2 million i.u., isoflurane usp/ip/bp, liquid for inhalation, 100ml bottle inj, erythropoitin, 10000i.u./1.0ml inj, p.f.s., rocuronium 50mg/5ml, inj 5ml amp, thiamine (vitamin b1), 200mg/2ml inj, octreotide 100mcg/ml, inj 1ml amp, vancomycin 1gm inj, artesunate 60 mg/ml inj, combipack, dexamethasone, sodium phosphate, 4mg/ml inj 2ml amp, desflurane 240ml bottle, doxycycline injection, 100mg vial combipack, tranexamic acid, 500mg/5ml inj, rabies vaccines, human (cell culture), potency of not less than, 2.5 units per vial i.p., for id use (tissue, culture anti rabies, vaccines) inj 1ml vial, iron sucrose 20mg/ml, 5ml amp inj, amoxycillin sodium, 1gm + clavulanic acid, 200mg per vial inj, amikacin sulphate 500, mg inj 2ml vial, tigicycline 50mg inj, levetiracetam, 100mg/ml inj 5ml vial, anti d (rho d), immunoglobulin, recombinant 300mcg inj, vial/pfs, heparin low molecular, weight 40mg/ 0.4ml inj, pfs, heparin low molecular, wieght 60mg/0.6ml inj, pfs, surfactant for, intratracheal instillation, (natural bovine lung, surfactant) minimum, labelled shelf life (in, months 18) 3ml, meropenem inj. 1gm, meropenem inj. 500mg, etomidate 20mg/10ml, inj 10ml amp, insulin degludec 100, units/ml 3ml inj pfp, metoclopramide, hydrochloride 5mg/ml, inj 2ml amp, rabies vaccines, human (cell culture), potency of not less than, 2.5 units per vial. i.p., for im use (tissue, culture anti rabies, vaccines) inj 1ml vial, surfactant for, intratrecheal instillation, (natural bovine lung, surfactant) minimum, labelled shelf life (in, months 18) 5ml, albumin human 20% inj, 100ml bottle, vancomycin hcl, 500mg inj, acyclovir 500mg inj, pantoprazole, 40mg/10ml inj 10ml vial, contrast non ionic, monomer 370mg/ml or, 350mg/ml or 300mg/ml, iohexol 50ml vial, piperacilin 4gm +, tazobactum 0.5 mg inj, sevoflourane 250ml, bottle, pralidoxime chloride, 1gm inj, paracetamol 10mg/ml, inj 100ml bottle, labetalol 5mg/ml 4ml, amp, acetylcysteine, 200mg/ml inj, sodium bi carbonate, 7.5% w/v inj 10ml amp, immunoglobulin human, normal 5% for, intravenous use 5gm, anti snake venom, serum (asvs), lyophilysed polyvalent, enzyme refined 10ml, vial, water for injection 5ml, amp sterile, tigecycline 50 mg, injection, erythropoietin, 4000iu/1.0ml inj pfs, i, contrast non ionic, monomer 370mg/ml or, 350mg/ml or 300mg/ml, iohexol 100ml bottle, i, pralidoxime chloride, 500mg inj, i, methyl prednisolone, sodium succinate, 1gm/vial inj, i, amphotericin b, 50mg/10 ml lyposomal, inj, i, porcine lung surfactant, 1.5ml injection, i, cefoperazone 1gm +, salbactum 0.5gm, injection, i, colistomithate 3 miu inj i, terlipressin acetate, 1mg/10ml 10ml, ampoule injection, i, vecuronium bromide, 4mg inj, i, insulin highly purified, human neutral inj, (regular) 40 i.u./ml, 10ml vial, i, noradrenaline 2mg/ml, inj 2ml amp, i, phenytoin sodium, 50mg/ml (diphenyl, hadantoin sodium) inj, 2ml amp, surfactant for, intratrecheal instillation, (natural bovine lung, surfactant) minimum, labelled shelf life (in, months 18) 4ml, ceftriaxone sodium, 1gm inj, meropenem 1 gm +, sulbactum 1gm inj,. The estimated project cost is ₹33.07 Cr, with an EMD of ₹0.33 Cr. Interested bidders can submit applications until 6 October 2026, with the technical opening scheduled for 7 October 2026.